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The understanding of the fixation of mutations within human
tissues and their subsequent clonal expansion is a considerable
problem, of which little is known. We have previously shown that
nononcogenic mutations in the mitochondrial genome occur in one
of a number of morphologically normal colonic crypt stem cells, the
progeny of which later occupy the whole crypt. We propose that
these wholly mutated crypts then clonally expand by crypt fission,
where each crypt divides into two mutated daughter crypts. Here
we show that (i) mutated crypts in the process of fission share the
same mutated mitochondrial genotype not present in neighboring
cytochrome c oxidase-positive crypts (the odds of this being a
random event are >2.48  109:1); (ii) neighboring mutated crypts
have the same genotype, which is different from adjacent cyto-
chrome c oxidase-positive crypts; (iii) mutated crypts are clustered
together throughout the colon; and (iv) patches of cytochrome c
oxidase-deficient crypts increase in size with age. We thus dem-
onstrate definitively that crypt fission is the mechanism by which
mutations spread in the normal human colon. This has important
implications for the biology of the normal adult human colon and
possibly for the growth and spread of colorectal neoplasms.
fission  mitochondria
Colorectal cancer is considered a disease of colonic tissuestem cells. The high turnover of cells within the crypt (1, 2)
means that stem cells are the only cell type that remain in the
crypt long enough to acquire sufficient prooncogenic mutations.
In addition, stem cells possess the ability to self renew, and if
cancer is seen as a dysregulation of self renewal, fewer mutations
may be required to activate this machinery. We have previously
argued that colorectal adenomas begin as a mutated stem cell at
the base of the crypt, whose progeny eventually colonize the
crypt to become a monocryptal or unicryptal adenoma, which
then expands by crypt fission (the ‘‘bottom-up’’ theory) (3).
Although this proposal is not universally accepted (4), it does
invoke a pivotal role for stem cells in carcinogenesis. At present,
little is known of the mechanisms by which DNA mutations
within morphologically normal colonic crypt stem cells are
established and spread throughout the nondysplastic colon.
Mitochondria are the major generators of cellular ATP
through oxidative phosphorylation. mtDNA is a small (16.6-kb)
self-replicating molecule that encodes 13 essential proteins of
the mitochondrial oxidative phosphorylation complexes, 2
rRNA and 22 tRNA genes. Within cells, there are thousands of
mitochondria, each containing multiple copies of mtDNA.
mtDNA mutations are random, increase with age (5, 6), and are
thought to occur because of the presence of free-radical-
generating enzymes, potentiated by poor DNA repair mecha-
nisms and the lack of protective histones (7, 8). These mutations
can affect all copies of the mitochondrial genome (homoplasmy)
or a proportion thereof (heteroplasmy). For a mutated mito-
chondrial genotype to result in a mutated cellular phenotype,
homoplasmy or high levels of heteroplasmy must be present (9).
In some cells, there is a high level of mutation involving the
mitochondrial cytochrome c oxidase genes and associated with
cytochrome c oxidase deficiency. We have shown that these cells
clonally expand to occupy first part and then the whole crypt
(also known as monoclonal conversion) (10), where the crypt
becomes entirely colonized by mutated cells. Such conversion
has previously been shown in mice that have DNA mutations in
nuclear housekeeping genes such as G6PD and metallothionein
induced by ethylnitrosourea (11, 12). Colonic crypts in mice (13)
and humans (14–16) are clonal populations; we have shown that
one of a number of colonic stem cells can acquire a mutation in
the mitochondrial genome, resulting in detectable cytochrome c
oxidase deficiency only after the age of 40.
Thus, in humans, one stem cell has the potential to expand and
replace the whole crypt stem cell population, either stochasti-
cally or by a selective advantage induced by the mutation, a
phenomenon known as niche succession after Kim and Shibata
(17). We and others have argued that these crypts then clonally
expand by crypt fission, dividing to form two daughter crypts,
and that this is the mechanism by which stem cell clones expand
in the colon and indeed in the entire gastrointestinal tract (11,
14). This proposal would predict that neighboring colonic crypts
are closely related to each other. We have previously shown that
the X-linked patch in the adult human colon is large, 450
crypts, so colonic crypts can develop into large families (15). But
this does not tell us anything about the development and spread
of mutations occurring later in life. Indeed, salient studies by
Kim and Shibata (18) have suggested that this simple proposal
is more complex: detailed analysis of the methylation status of
nonexpressed genes, such as MyoD, showed that adjacent crypts
are no more related to each other than those 15 cm away;
moreover, crypts in fission showed the same differences. This
could mean either that crypts apparently in fission are fusing
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rather than dividing (17, 19, 20), or that the fission process is so
protracted that niche succession occurs in the dividing partners.
In this study, we show that morphologically normal human
colonic crypts are able to divide by crypt fission by demonstrat-
ing that stochastic mutations in mtDNA resulting in a phenotypic
deficiency of cytochrome c oxidase are identical in both arms of
a crypt that is bifurcating. Furthermore, we show that patches of
neighboring crypts deficient in cytochrome c oxidase also share
identical mitochondrial mutations, indicating that crypt fission is
a mechanism by which mutations can spread within the colon.
Also, we calculate the statistical likelihood that crypts deficient
in cytochrome c oxidase are clustered and demonstrate that
patches of mutated crypts increase in size with age, providing
further evidence of the development of clonal patches in the
human colon.
Results
Normal Human Colonic Crypts Divide and mtDNAMutations Spread by
Crypt Fission. We first determined that a crypt, in the process of
fission, maintains mtDNA mutations in both daughter crypts.
Single cytochrome c oxidase-deficient cells from both arms of a
bifurcating wholly cytochrome c oxidase-deficient crypt, in ad-
dition to cells from cytochrome c oxidase-positive neighboring
crypts, were microdissected (Fig. 1 a–i), and the sequence of the
entire mitochondrial genome was determined in all of the cells.
This identified an mtDNA mutation, 4733TC in the MTND2
gene, in cells from both arms of the cytochrome c oxidase-
deficient crypt in fission (Fig. 1k), whereas the cytochrome c
oxidase-positive cells maintained their wild-type genotype (Fig.
1j). Whereas the 4733TC mutation predicts a synonymous
change and is probably not the reason for the observed cyto-
chrome c oxidase deficiency, it does show that a single mutation
is able to persist in newly forming crypts. Furthermore, this
analysis provides evidence that crypts divide by fission.
Crypt mtDNA Mutations Spread to Form Clonal Patches.We hypoth-
esized that, if any given mtDNA mutation were able to establish
itself in the stem cell population of newly formed crypts over
time, the mutation would appear in other neighboring crypts as
fission was repeated, resulting in the formation of a patch. To test
this theory, we sequenced the entire mitochondrial genome from
single colonocytes microdissected from three neighboring cyto-
chrome c oxidase-deficient crypts (none of which was undergo-
ing fission), in addition to colonocytes from three neighboring
cytochrome c oxidase-positive crypts. A total of 17 recognized
polymorphic variants were found in all six of the cells that were
sequenced. However, all of the colonocytes from the three
cytochrome c oxidase-deficient crypts harbored an additional
mutation, 6277AG, in the mitochondrial cytochrome c oxidase
I gene, which predicts a Gly125Asp amino acid substitution in
cytochrome c oxidase protein (Fig. 2a). Gly-125 is very highly
conserved throughout evolution (21) and as such is highly likely
to be the cause of the cytochrome c oxidase deficiency. The same
mutation was not seen in any of the adjacent cytochrome c
oxidase-positive crypts that were sequenced (Fig. 2b). In another
patient, the same protocol revealed not one but two shared
mutations found in both cytochrome c oxidase-deficient crypts
[a 7275TC transition mutation, which predicts a Ser458Pro
Fig. 1. Both arms of a cytochrome c oxidase-deficient crypt in fission share identical mutations. (a–i) Serial sections were made of a single crypt in fission, and
single cells were isolated from each arm and from a single neighboring cytochrome c oxidase-positive crypt. Cells from both arms of the cytochrome c
oxidase-deficient crypt in fission had a common 4733 TC transition j is the neighboring cytochrome c oxidase-positive crypt, and k is from the deficient crypt
in fission.
Fig. 2. Single cells were isolated from each of the cytochrome c oxidase-
deficient crypts and from adjacent cytochrome c oxidase-positive crypts. In
one patient, each cytochrome c oxidase-deficient cell had a 6277 AG tran-
sition (a) which is not present in the cytochrome c oxidase-positive cells (b). In
another patient, each cytochrome c oxidase-deficient cell had a 7275 TC
transition (c) and a C311 insertion (e) not present in the cytochrome c oxidase-
positive cells (d and f ).
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amino acid substitution in the mitochondrial cytochrome c
oxidase I gene (Fig. 2c) and a neutral polymorphic variant
(C303ins) variant (Fig. 2e)]. Neither 7275TC nor the C303ins
was present in adjacent cytochrome c oxidase-positive crypts
(Fig. 2 d and f).
Phenotypically Identical Crypts Are Clustered. Sequencing analysis
gives a very strong indication of how mtDNA mutations spread
within the human colon at the crypt level but not the overall
picture of what is happening in the colon. We studied 14 patients
and identified cytochrome c oxidase-deficient crypts by immu-
nohistochemistry. We therefore labeled each crypt as either
cytochrome c oxidase-positive or -deficient in an entire field (X
no. crypts per field 1,337 94.83) and applied a Monte–Carlo
simulation method to derive a control probability distribution of
crypt cluster statistics, against which the same statistics mea-
sured on each sample is compared (Materials and Methods). To
achieve this, two computer programs [BIAQIM and CLAN (cluster
analysis), Tadrosoft] were used. BIAQIM was used to spatially
map cytochrome c oxidase-deficient and -positive crypts
throughout a low-power (20) en face image of the colon. CLAN
statistically determined the relative risk (RR) that a cytochrome
c oxidase-deficient crypt also has at least one other cytochrome
c oxidase-deficient crypt as a nearest neighbor, 2, and the
proportion (Nprop) of all cytochrome c oxidase-deficient crypts
with at least one other as a nearest neighbor. To achieve
significance, each observed data set was compared with 1,000
control probability distributions (random data sets), and signif-
icance was taken as 95% of random data sets being less than
the observed data set. Fig. 3a shows the frequency of all images’
RR. Only images taken from patient 11 had a RR1 (indicating
no statistical clustering within that patient). Observed RR of1
indicate deficient crypts are clustered. When compared with
1,000 random assignations of cytochrome c oxidase-deficient
labels, 91.18% (3134) images achieved 95% RR significance,
82.35% (2834) achieved 95% 2 significance, and 88.24%
(3234) achieved 95% Nprop significance (Fig. 3b and Table 1,
which is published as supporting information on the PNAS web
site). On the rare occasion that an individual image did not reach
the 95% level, there was at least one other image from that
patient that did, or that patient was the younger of the patients
in whomwewould not expect to see statistical clustering, because
so few mutated crypts were present. Analysis was performed by
two independent observers. No intraobserver bias was found
(Fig. 3c) on 15 randomly selected images from a total of 34. We
have shown (10) that the number of cytochrome c oxidase-
deficient crypts increases with age, and this patient data set
shows a similar age-dependent increase (see Fig. 6, which is
published as supporting information on the PNAS web site).
Patient 11 (40 years old) did not show any statistical clustering
of mutated crypts, and this would fit with age-dependent obser-
vations. Statistical analysis has confirmed that cytochrome c
oxidase-deficient crypts are indeed clustered within the normal
human colon and provides conclusive evidence in support of the
development of the patch.
Patches of Phenotypically Identical Crypts Expand with Age.We have
shown that phenotypically and genotypically identical crypts are
able to divide by fission into a patch of at least two crypts or
more. We have also shown that these crypts are statistically
clustered together. A prediction could therefore be made that
patch size would increase with age. To test this hypothesis, we
calculated the mean patch size of cytochrome c oxidase-deficient
crypts within colonic tissue sections of 34 patients. A patch was
defined as at least two phenotypically identical crypts in juxta-
position to each other within the width of a single crypt. The
mean patch size versus age is shown in Fig. 4, which shows that
there is an age-dependent increase in patch size (R2  0.8741).
Discussion
We have demonstrated that the progeny of a morphologically
normal human colonic crypt stem cell that contains an mtDNA
mutation can expand to occupy a whole crypt, and that this crypt
then further expands by fission to form a patch (illustrated in Fig.
5). This study demonstrates that crypt fission is an active process
of clonal expansion of crypts in the normal human intestine.
Previously, it had been shown that in the normal adult human
colon, all crypts were monoclonal in nature (16), but this study
demonstrates in humans that clonal patches develop by crypt
fission.
Other researchers have argued that what was thought to be
fission was actually fusion of two crypts colliding (17–19). We
have shown here that both arms of a bifurcating crypt have
identical mtDNAmutations; the odds of this occurring by chance
are so small (at least 2.48  109:1, perMaterials and Methods) as
to refute the possibility of two identically mutated crypts merg-
Fig. 3. Analysis of CLAN-generated data. (a) The observed RR for any image
was 1 in all patients except patient 11 (40 years of age) who had very few
mutated crypts. (b) Observed versus randomly generated data for RR, 2, and
Nprop (91.18%, 82.35%, and 88.24%, respectively) for all images achieved
significance at the 95% level. (c) All images were analyzed by two indepen-
dent researchers in a blinded fashion, and no intraobserver differences were
found [correlation coefficient (R2) of 0.85].
716  www.pnas.orgcgidoi10.1073pnas.0505903103 Greaves et al.
ing. We have no reason to believe that the biology of cytochrome
c oxidase-deficient crypts differs from cytochrome c oxidase-
positive crypts (10).
The data of Kim and Shibata (17, 18) indicate, therefore, that the
process of clonal expansion by crypt fission is slow, and that it would
be useful to combine mtDNA genotyping and CpG methylation
status in the same crypts. Our data would predict that, in conditions
such as ulcerative colitis, where crypt fission is prominent, patches
would be larger. This is a testable hypothesis ongoing in our
laboratories, which also underlines the potential importance of
crypt fission in the spread of dysplasias and neoplasms in the gut.
In fact, in ulcerative colitis with dysplasia, the same aneuploid stem
cell line can be found in large areas of mucosa (22). Our results
would also predict that when a crypt becomes filled with dysplastic
cells, it can then divide by fission, and it is by consecutive fission
events that a dysplastic crypt expands into aberrant crypt foci. It is
likely that such a mechanism is also responsible for the spread of
mutated clones in the stomach and the esophagus in Barrett’s
mucosa; rapid expansion, for example of p16/ clones, has been
reported (23).
Our data could be extrapolated to conform to the ‘‘bottom-
up’’ pattern of dysplastic spread (3). An adenomatous crypt
would, therefore, begin to divide from the base of the crypt at
the stem cell region and bifurcate into two adenomatous daugh-
ter crypts. Previous studies have shown there is a significant
increase in the amount of crypt budding and bifurcation in
patients with familial adenomatous polyposis (24, 25), and the
data we have presented here have provided a likely mechanism
by which the early development of aberrant crypt foci develop.
As yet, the mechanism(s) initiating fission are unknown but may
include the control of stem cell number by factors such as the
bone morphogenic proteinSMAD4 pathway (26).
Taken together with the results of Kim and Shibata, who have
shown that adjacent colonic crypts and even crypts in fission have
quite dissimilar methylation patterns, it seems that crypt fission
may take a long time in the human. In the mouse, the time for
fission appears to take12 h, with a possible crypt cycle time of
112 days (27). It has also been suggested that normal adult
crypts in the human colon divide every 17 years (27, 28). A fission
time of 27 months does not seem unreasonable, which could be
the coefficient time for such divergence in methylation signa-
tures to occur.
We have previously shown that the adult colon has large families
of adjacent crypts (450) (15), which show the sameX-linked gene,
indicating that after lyonization, early stem cells from the colonic
mucosal crypts expand, implicitly by crypt fission, to form large
families of related crypts, so far as sharing the sameX-chromosome
is concerned. However, Kim and Shibata results (17, 18) show that
the methylation patterns of adjacent crypts diverge markedly by
stem cell niche succession, but every 8 years or so, a ‘‘bottleneck’’
is reached, where all stem cells in the crypt are closely related.
Superimposed on this process, throughout life, is crypt fission,
whereby a crypt expands to form a group or patch of closely related
crypts, insofar as the genotype is concerned, evenwhile their unique
methylation patterns are diverging.
Materials and Methods
Patients. For cluster analysis, 1.0  1.5-cm blocks of morpho-
logically normal colonic mucosa were taken from colectomy
specimens of 14 patients with colorectal cancer (10 patients),
diverticular disease (3 patients), or cecal stricture (1 patient).
Blocks were selected from outside the resection margins of
tumors and, in the case of diverticular disease, in noninflamed
mucosa. Specimens were either fixed in 4% paraformaldehyde
and embedded in paraffin or snap-frozen in liquid nitrogen-
cooled isopentane. For patch-size analysis, the same 14 patients’
blocks were used plus blocks taken from an additional 20
patients stored in tissue archives, reorientated en face. Reori-
entated blocks were not of sufficient size and continuity to
perform cluster analysis. Ethical approval was sought and ob-
tained from the Newcastle and North Tyneside Local Research
Ethics Committees and the University College Hospital Re-
search Ethics Committee.
Immunohistochemistry. Colonic sections were cut to a thickness of
4 m. Antigen retrieval was performed by pressure cooking the
slides for 3 min in boiling 0.1 M sodium citrate buffer, pH 6.0,
after dewaxing them in xylene and rehydrating then through
decreasing ethanol and finally with distilled water. Nonspecific
staining was blocked by adding protein block serum-free ready-
to-use buffer (DAKO) for 15 min then washed three times in
Tris-buffered saline with 0.1% Triton X-100. A 1:100 dilution of
mouse anti-human cytochrome c oxidase subunit I was made in
TrisTriton X-100 and applied to the sections for 30 min in a
Fig. 4. Mean patch size of cytochrome c oxidase-deficient crypts increases
with age. Patients have been grouped according to decade (31–40, 41–50,
51–60, 61–70, 71–80, and 81–90). Results are  SEM. Although individual
deficient crypts were observed in patients under the age of 40, no patches of
two or more deficient crypts were seen. R2  0.8741, and the equation of
best-fit curve is y  0.20090.03295x.
Fig. 5. A proposed model of how DNA mutations spread in the human colon.
The initial mutation can occur anywhere within the epithelium but can persist
only in stem cells. Occasionally, a stem cell carrying a DNA mutation can
dominate the crypt, leading to all cells within that crypt also carrying the
mutation. At some point, this crypt will divide by fission, and this process will
carry on through the life of the host. If the mutation is prooncogenic, this may
affect the rate at which this occurs, resulting in a rapid spread of potentially
cancerous mutations.
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humid chamber. Slides were then washed three times in TBS
Triton. Sections were then incubated in neat CheMate (Envi-
sion) anti-rabbitanti-mouse conjugated with horseradish per-
oxidase (DAKO) and developed in 4 mM diaminobenzidene
tetrachloride (DAKO). The sections were lightly counterstained
in haematoxylin, dehydrated through increasing ethanol washes,
cleared with xylene, and mounted in DPX. Isotype-matched and
without primary controls revealed no nonspecific staining.
Histochemistry. Frozen colon samples were mounted in OCT com-
pound for sectioning. Sequential histochemical staining for cyto-
chrome c oxidase and succinate dehydrogenase histochemistry (the
presence of which was used to highlight the absence of cytochrome
c oxidase activity) was carried out on 20-m transverse sections as
follows. Sections were first incubated in cytochrome c oxidase
incubation medium (100 M cytochrome c4 mM diaminobenzi-
dine tetrahydrochloride20 g/ml catalase in 0.2 M phosphate
buffer, pH 7.0) for 50 min at 37°C. They were then washed in PBS,
pH 7.4, for 3  5 min and incubated in SDH incubation medium
(130 mM sodium succinate200 M phenazine methosulphate1
mM sodium azide1.5 mM nitroblue tetrazolium in 0.2 M phos-
phate buffer, pH 7.0) for 45 min at 37°C. Sections were washed in
PBS for 3  5 min, dehydrated in a graded ethanol series (70%,
95%, and 100%) and left to air dry for 1 h.
Isolation of Total DNA from Individual Cells. Single cells from
cytochrome c oxidase-deficient and cytochrome c oxidase-
positive crypts were cut into sterile 0.5-ml PCR tubes by using the
Leica (Deerfield, IL) Laser Microdissection (AS-LMD) System.
After centrifugation (7,000  g for 10 min), the cell was lysed in
14 l of cell lysis buffer (50 mM TrisHCl, pH 8.51 mM
EDTA0.5% Tween-20200 ng/ml proteinase K) at 55°C for 2 h
and then 95°C for 10 min to denature the proteinase K.
mtDNA Sequencing of Individual Colonocytes. The entire sequence
of the mitochondrial genome from microdissected crypts was
determined by using DNA extracted from single-cell lysates (see
above). The mitochondrial genome was amplified in overlapping
fragments by using a series of M13-tailed oligonucleotide primer
pairs, as described (29). PCR products were sequenced by using
BigDye Ver. 3.1 terminator cycle sequencing chemistries on an
ABI Prism 3100 Genetic Analyzer (Applied Biosystems) and
compared directly with the revised Cambridge reference se-
quence (rCRS) by using SEQUENCE ANALYSIS and SEQSCAPE
software (Applied Biosystems), as described (29).
Image Analysis for Spatial Clustering. Low-power (20) digital
images of tissue sections of normal colonic mucosa, cut en face,
stained with anticytochrome c oxidase subunit 1, were captured
by using an Optronics Magnafire digital microscope camera
(Optronics International, Chelmsford, MA). A maximum of
three individual images were taken from different sites on each
section and up to two blocks used from the same patient taken
from different regions of the colon. A total of 29 images (from
a total of 10 patients) were of sufficient quality to use for
analysis. Images with inominate grooves, inflammation, or areas
with luminal spaces were discarded.
To determine the presencestrength of any spatial clustering of
cytochrome c oxidase-deficient colonic crypts, we devised amethod
that calculates three separate statistical measures of spatial clus-
tering, that takes into account the actual geometrical configuration
of crypts in the colonic mucosal images under study, and that does
not make assumptions about specific simplified geometries [e.g., we
do not assume the crypts are arranged in an orderly hexagonal
array, as in some previous methods of cluster analysis (30)]. The
method, for each image, is divided into an interactive step and an
automated step. The interactive step involves generating a simpli-
fied labeled image of crypt positions and types, which is then fed as
input into the second step, a custom-written program (called CLAN
for cluster analysis, Tadrosoft, London) that performs the statistical
analysis. The simplified labeled image was made by marking the
center point of all of the crypts in each field with a single pixel, and
each of these pixels was labeled by the operator as either cyto-
chrome c oxidase-deficient (called an index crypt) or -positive (a
background crypt). This was performed by using the freely available
BIAQIM image analysis software. The labeled image was then
analyzed by CLAN, which measured the value of the three cluster
statistics (defined below) and also generated control distributions
for each of these statistics by measuring the value of that statistic on
1,000 random images. Each random image was generated by
randomly assigning crypt pixels to either index or background status
while keeping the absolute number of index and background pixels,
as well as the positions of all pixels, the same as for the image under
study (thus a control distribution is calculated for each image as well
as for each of the three statistics). In this way, the original geometric
configuration of colonic crypts is taken into account when gener-
ating control probability distributions rather than assumptions
being made about idealized configurations.
Definition of Cluster Statistics. Nprop.The proportion of index crypts
in an image with at least one adjacent crypt also of index (i.e.,
cytochrome c oxidase-deficient) type.
RR. The RR of an index crypt also having adjacent neighbors that
are also of index type calculated as;
RR
nˆ i i nˆ i
p
,
where nˆii is the mean number of index crypt adjacent neighbors
that are also index crypts, nˆi is the mean number of index crypt
adjacent neighbors, and p is the proportion of all crypts in the
image field that are of index type.
2. A 2 statistic calculated as
2 
i
ri nip	2
nip
,
where the summation is over all index crypts, i.
In the above definitions, the definition of a crypt as being
‘‘adjacent’’ to any given index crypt was based on an exclusion
circle of radius Ra, where all crypts closer than Ra pixels from a
given index crypt are considered adjacent neighbors of that index
crypt. The value of Ra was chosen as Ra  X 
 5SD, where X is
the mean of the minimum distance of each crypt to its closest
neighbor calculated from all crypts in a given image, and SD is
the standard deviation of these minimum distances. This choice
of Ra was arrived at empirically, because it was found to agree
well with an exclusion radius based on actual measurements of
the distances from any given crypt to its immediately adjacent
neighbors on a sample of index crypts. Because this is a statistical
measure of adjacency, an heuristic constraint was enforced to
ensure that Ra was a reasonable measure of crypt adjacency in
that only those index crypts with five or six adjacent neighbors
(defined by using the Ra exclusion radius) were eligible for
calculation of the statistics. This heuristic is based on the
observation that very few crypts have seven or more or four or
less adjacent neighbors. The vast majority of crypts in each image
studied were found to be eligible for analysis by these criteria.
Patch-Size Analysis. A patch was defined as at least two cyto-
chrome c oxidase-deficient crypts in juxtaposition to one another
within a distance of no more than the width of a single crypt.
Paraffin-embedded blocks were taken from 34 patients (age
range of 35–85 years), which were previously stored in tissue
archives. The blocks were reorientated to provide an en face
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image. Tissue sections were subjected to immunohistochemistry
(described above) for cytochrome c oxidase. The numbers of
completely deficient crypts within each patch were counted
manually at a magnification of 200. Results were expressed as
the mean patch size per patient  SEM. The mean number of
crypts per image was 489.4  202.45.
Odds Ratios. The minimal odds of two random identical mtDNA
mutations occurring at the same site in two separate crypts by
chance were calculated as [16,600:1 (genome size)  3 (possible
transition mutations)] [16,600:1 3] 2.48 109:1. This does
not take into consideration that other types of mutations are also
found; therefore, it provides only minimal odds.
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